SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : NexOptic Technology Corp
NXOPF 0.001400.0%Dec 9 1:11 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: togrok5/10/2018 8:35:27 PM
   of 110
 
Review of the International Search Report (ISR) prepared 13 March 2018 by the Canadian Intellectual Property Office (CIPO)

I have reviewed the International Search Report (ISR) prepared 13 March 2018 by the Canadian Intellectual Property Office (CIPO) out of the international (PCT) counterpart (PCT/IB2017/001457) to the US patent application (Ser. No. 15/795,145) and see that all claims are considered novel, but about half of them are found to lack inventive step (which means they are considered to be obvious over the cited prior art).

Specifically, claims 1, 3-5, 9, and 13-17 are said to lack inventive step. Claims 2, 6-8, 10-12, and 18-20 have no prior art problems (according to the CIPO examiner), and claim 18 has only two very minor formal problems that can be readily corrected by amendment.

The USPTO and most other major patent offices will conduct a further examination and are free to raise other rejections if they find additional prior art, but if prosecution of this one goes as it did for the Blade Optics patent, nothing else of significance will turn up. If that is the case, claims 2, 6-8, 10-12, and 18-20 will be allowed in the first Office Action (assuming the problems with claim 18 are corrected before then).

You can view the US application and all documents in the file at portal.uspto.gov
and enter the application number 15/795145

GLTAL, Jeff
stockhouse.com

For further clarification, the ISR serves as a starting point for the examiner in each country in which NXO enters examination of this patent application. NXO will have the opportunity in each country to disagree with the conclusions in the ISR, argue against rejections of any claims, and further amend the claims in attempts to get them in better condition for allowance.

This ISR is a good indication that many more patents are coming.

GLTAL,
Jeff
stockhouse.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext